CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research aims to develop targeted therapies for congenital vascular malformations by isolating and characterizing endothelial cells from affected tissues. It explores the potential of reprogramming these cells to improve treatment outcomes for disfiguring lesions.
Congenital Vascular Malformations (CVM) are a group of diseases characterized by an inborn, localized defects of vascular morphogenesis.
Occurring mainly on the face or other highly visible part of the body, the presence of CVM can cause emotional and social problems.
Moreover, some malformations are painful or even life-endangering.
Current treatments do not achieve optimal or long-lasting results.
Thus, there is a pressing need for therapies that are more effective for these disfiguring lesion…
MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
